Caplin Point Laboratories Market Cap

Caplin Point Laboratories has a market cap or net worth of 131.65 billion as of April 29, 2026. Its market cap has decreased by -10.63% in one year.

Market Cap

131.65B

Enterprise Value

122.67B

Revenue

20.92B

Ranking

n/a

PE Ratio

21.51

Stock Price

1,731.95

Market Cap Chart

Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 131.65B, an increase of 2,351,185.17%. That is a compound annual growth rate of 51.62%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	131.65B	-5.93%
Dec 31, 2025	139.95B	-26.39%
Dec 31, 2024	190.12B	84.60%
Dec 29, 2023	102.99B	90.47%
Dec 30, 2022	54.07B	-16.82%
Dec 31, 2021	65.01B	69.50%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jubilant Pharmova	149.60B
Rubicon Research	154.65B
CORONA Remedies	99.90B
Granules India	170.76B
Viyash Scientific	90.17B
Procter & Gamble Health	85.33B
AstraZeneca Pharma India	212.54B
Sanofi India	79.01B

Market Cap Rankings